%PDF-1.7
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2017-06-02T09:17:55-04:00
2017-06-02T09:17:58-04:00
2017-06-02T09:17:58-04:00
Adobe InDesign CC 2017 (Windows)
uuid:d0a2fc46-49a9-4fb5-9398-32908f784fea
xmp.did:4A42F9656056E111960DCE8E95F0DF9D
xmp.id:e16312f9-7e0f-f148-9faa-fa9657f0d5d0
proof:pdf
xmp.iid:999570de-05e4-c34d-8a75-f3dcbfc0eb03
xmp.did:401a2ec8-518d-3546-86d5-b8220679834b
xmp.did:4A42F9656056E111960DCE8E95F0DF9D
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 2017 (Windows)
/
2017-06-02T09:17:55-04:00
application/pdf
Adobe PDF Library 15.0
False
endstream
endobj
3 0 obj
<>
endobj
5 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
6 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
11 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
12 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
39 0 obj
<>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
BT
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc 8.5 0 0 8.5 171.2281 451.358 Tm
(1.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(A large observational study of white-coat)-10 ( )]TJ
0 -1.2 TD
(hypertension showed:)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 TD
(a. it occurs in about 10% of those with )Tj
0 -1.2 TD
(normal ambulatory blood pressure.)Tj
0 -1.729 TD
(b. it is associated with a higher risk of )Tj
0 -1.2 TD
(cardiovascular events.)Tj
0 -1.729 TD
(c. it predicts cardiovascular risk in those < 60 )Tj
0 -1.2 TD
(years of age.)Tj
0 -1.729 TD
(d. the magnitude of the effect is correlated to )Tj
0 -1.2 TD
(the degree of cardiovascular risk.)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc -1.588 -2.894 Td
(2.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(Bioabsorbable coronary stents as compared to)-10.1 ( )]TJ
T*
(drug-eluting metal stents:)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 TD
(a. reduced in-stent restenosis.)Tj
T*
(b. increased stent thrombosis events.)Tj
T*
[(c. improved vasoreactivity)92 (.)]TJ
T*
[(d. improved exercise capacity)92 (.)]TJ
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc -1.588 -2.894 Td
(3.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(The addition of left atrial appendage ablation)-10 ( )]TJ
0 -1.2 TD
[(to standard ablation for long-term persistent)-9.9 ( )]TJ
T*
(atrial \037brillation resulted in:)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 TD
[(a. increased mortality)92 (.)]TJ
0 -1.729 TD
(b. increased stroke rate.)Tj
0 -1.729 TD
(c. more subsequent hospitalizations.)Tj
0 -1.729 TD
(d. more patients in sinus rhythm.)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc 21.308 36.141 Td
(4.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(The happy heart syndrome is an unusual)-10 ( )]TJ
0 -1.2 TD
(variant of:)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 TD
(a. the holiday heart syndrome.)Tj
T*
(b. takotsubo syndrome.)Tj
0 -1.729 TD
[(c. stress cardiomyopathy)92 (.)]TJ
0 -1.729 TD
(d. acute cerebral bleed associated left )Tj
0 -1.2 TD
(ventricular dysfunction.)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc -1.588 -2.894 Td
(5.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(In a large study that randomized patients to)-10 ( )]TJ
0 -1.2 TD
[(enalapril vs. sacubitril/valsartan, the addition)-10 ( )]TJ
0 -1.2 TD
(of mineralocorticoid antagonists resulted in:)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 TD
(a. no change in potassium levels in either )Tj
0 -1.2 TD
(group.)Tj
0 -1.729 TD
(b. more severe hyperkalemia in the enalapril )Tj
0 -1.2 TD
(group.)Tj
0 -1.729 TD
(c. more severe hyperkalemia in the sacubitril/)Tj
0 -1.2 TD
(valsartan group.)Tj
0 -1.729 TD
(d. more severe hyperkalemia in both groups.)Tj
10 0 0 10 163.2662 736.28 Tm
(contributor to the lumen difference at three )Tj
0 -1.217 TD
(years. Following updated implantation )Tj
T*
(recommendations could yield a different )Tj
T*
(and more positive result for BVS. Whether )Tj
T*
(the added time and expense of optimal )Tj
T*
(implantation techniques are worthwhile )Tj
T*
(for a majority of patients \227 when a less )Tj
T*
(resource-intensive approach yields excellent )Tj
T*
(results with metallic stents \227 is an open )Tj
T*
(question. Even with the apparently subopti)Tj
(-)Tj
T*
(mal technique used in this trial, results with )Tj
T*
(the BVS were overall very good, and event )Tj
T*
[(rates were reassuringly low)92.1 (.)]TJ
0 -2.435 TD
(An important and often-forgotten part )Tj
0 -1.217 TD
(of the equation here is duration of dual )Tj
T*
[(antiplatelet therapy \(DAPT\). W)18.1 (ith metal)]TJ
(-)Tj
0 -1.217 TD
(lic stents, the safety of shorter and shorter )Tj
0 -1.217 TD
(DAPT duration has been the clear trend. )Tj
0 -1.217 TD
(Current U.S. and ESC guidelines recom)Tj
(-)Tj
T*
(mend six months of DAPT after elective )Tj
20.299 24.348 Td
(PCI with metallic stents, and multiple stud)Tj
(-)Tj
T*
(ies have suggested safety of three months or )Tj
T*
(even less. The thicker struts of the Absorb )Tj
T*
(scaffold, along with other factors, leads )Tj
T*
(most experts to suggest that the optimal )Tj
T*
(duration of DAPT with this technology )Tj
T*
(is signi\037cantly longer than with metallic )Tj
T*
[(stents. This area will require further study)92.2 (, )]TJ
T*
(but for now many are recommending a full )Tj
T*
(year or even more of DAPT post-implant )Tj
T*
(for the Absorb.)Tj
0 -2.435 TD
[(For now)92 (, the Absorb BVS has its best avail)]TJ
(-)Tj
0 -1.217 TD
(able data in younger patients with non-)Tj
T*
(complex disease in vessels larger than 2.5 )Tj
T*
(mm. Whether the long-term promise of this )Tj
T*
(technology will be realized with current or )Tj
0 -1.217 TD
(future iterations of the device, in concert )Tj
0 -1.217 TD
(with greater experience with patient and )Tj
0 -1.217 TD
(lesion selection and implantation technique, )Tj
T*
(remains to be seen. )Tj
/C2_0 1 Tf
<0084>Tj
ET
q
/GS0 gs
96.355003 0 0 192.7099981 28.599987 102.1700068 cm
/Im0 Do
Q
endstream
endobj
40 0 obj
<>
endobj
42 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
/CS0 cs 0.07 scn
/GS0 gs
18 89.28 120.33 666.72 re
f
18 36 539.325 53.473 re
f
BT
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 7 0 0 7 27.8983 78.3659 Tm
(Interested in reprints or posting an article to your )Tj
0 -1.143 TD
[(company)-55.8 (\222s site? There are numerous opportunities for )]TJ
0 -1.143 TD
(you to leverage editorial recognition for the benefit of )Tj
0 -1.143 TD
(your brand. Call us at \(800\) 688-2421 or email us at )Tj
T*
[(R)17.6 (eprints@AHCMedia.com.)]TJ
25.217 4.571 Td
(Discounts are available for group subscriptions, multiple )Tj
T*
(copies, site-licenses, or electronic distribution. For pricing )Tj
0 -1.143 TD
(information, please contact our Group Account Managers )Tj
0 -1.143 TD
(at Groups@AHCMedia.com or \(866\) 213-0844.)Tj
19.48 0 Td
( )Tj
5.737 3.429 Td
[(T)175 (o reproduce any part of AHC newsletters for )]TJ
T*
(educational purposes, please contact The Copyright )Tj
0 -1.143 TD
(Clearance Center for permission at info@copyright.com )Tj
0 -1.143 TD
(or \(978\) 750-8400.)Tj
ET
/CS0 CS 1 SCN
3 w 4 M 0 j 0 J
/GS0 gs
q 1 0 0 1 138.6633 754.5 cm
0 0 m
437.337 0 l
S
Q
/CS0 cs 1 scn
163.328 464.32 392.414 17.367 re
f
0.25 w
163.391 98.045 392.225 366.149 re
S
BT
0 0 0 0 k
12 0 0 12 304.0168 468.4156 Tm
(CME/CE QUESTIONS)Tj
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
7 0 0 7 26.64 742.5959 Tm
(PHYSICIAN EDITOR)Tj
( )Tj
/TT0 1 Tf
0 -1.214 TD
[(Michael H)17.9 (. Crawford, MD)]TJ
/TT1 1 Tf
0 -1.214 TD
[(P)35.7 (rofessor of Medicine)]TJ
0 -1.214 TD
(Chief of Clinical Cardiology )Tj
10.628 0 Td
( )Tj
-10.628 -1.214 Td
(University of California )Tj
8.894 0 Td
( )Tj
-8.894 -1.214 Td
[(San F)54.9 (rancisco)]TJ
/T1_0 1 Tf
0 -2.429 TD
(PEER REVIEWER)Tj
/TT0 1 Tf
0 -1.214 TD
(Susan Zhao, MD)Tj
/TT1 1 Tf
0 -1.214 TD
(Director )Tj
( )Tj
0 -1.214 TD
[(Adult Echocardiography L)17.3 (aboratory)]TJ
0 -1.214 TD
[(Associate Chief)34.9 (, Division of Cardiology)86.4 (, )]TJ
0 -1.214 TD
(Department of Medicine)Tj
0 -1.214 TD
[(Santa Clara V)53.9 (alley Medical Center)]TJ
/T1_0 1 Tf
0 -2.429 TD
(NURSE PLANNER)Tj
/TT0 1 Tf
0 -1.214 TD
[(Aurelia Macabasco)-18.9 (-)-36.5 (O)17.8 (\222Connell, PhD, )]TJ
0 -1.214 TD
[(A)17.5 (CNP)78 (-BC, RN, PHN, F)36.7 (AHA)]TJ
/TT1 1 Tf
0 -1.214 TD
[(Associate P)35.3 (rofessor)]TJ
0 -1.214 TD
[(Azusa P)54.6 (acific University School of )]TJ
0 -1.214 TD
(Nursing)Tj
/T1_0 1 Tf
0 -2.715 TD
[(EDITORIAL ADVISOR)92.1 (Y BOARD)]TJ
/TT0 1 Tf
0 -1.214 TD
[(Cara P)35.6 (ellegrini, MD)]TJ
/TT1 1 Tf
0 -1.214 TD
[(Assistant P)34.8 (rofessor of Medicine, )]TJ
0 -1.214 TD
[(University of California, San F)54 (rancisco)]TJ
0 -1.214 TD
(Cardiology Division, Electrophysiology )Tj
T*
(Section)Tj
0 -1.214 TD
[(San F)54.9 (rancisco V)54.9 (A Medical Center)]TJ
/TT0 1 Tf
0 -2.429 TD
[(V)54.9 (an Selby)87.2 (, MD)]TJ
/TT1 1 Tf
0 -1.214 TD
[(Assistant P)34.8 (rofessor of Medicine, )]TJ
0 -1.214 TD
[(University of California, San F)54 (rancisco )]TJ
T*
(Cardiology Division, Advanced Heart )Tj
0 -1.214 TD
[(F)35.9 (ailure Section)]TJ
/TT0 1 Tf
0 -2.5 TD
(Jeffrey Zimmet, MD, PhD)Tj
/TT1 1 Tf
0 -1.214 TD
[(Associate P)35.3 (rofessor of Medicine)]TJ
0 -1.214 TD
[(University of California, San F)54 (rancisco)]TJ
0 -1.214 TD
[(Director)100.5 (, Cardiac Catheterization )]TJ
0 -1.214 TD
[(L)17.4 (aboratory)]TJ
0 -1.214 TD
[(San F)54.9 (rancisco V)54.9 (A Medical Center)]TJ
/T1_0 1 Tf
0 -2.429 TD
(EDITOR)Tj
/TT1 1 Tf
( )Tj
/TT0 1 Tf
0 -1.214 TD
(Jill Drachenberg)Tj
/T1_0 1 Tf
0 -2.429 TD
[(ASSIST)74 (ANT EDITOR)]TJ
/TT1 1 Tf
( )Tj
/TT0 1 Tf
0 -1.214 TD
(Jonathan Springston)Tj
/T1_0 1 Tf
0 -2.715 TD
[(SENIOR ACCREDIT)74.1 (A)74 (TIONS )]TJ
0 -1.214 TD
(OFFICER)Tj
/T1_1 1 Tf
( )Tj
/TT0 1 Tf
0 -1.214 TD
(Lee Landenberger)Tj
ET
endstream
endobj
43 0 obj
<>/Filter/FlateDecode/Height 1071/Intent/RelativeColorimetric/Length 93150/Name/X/SMask 48 0 R/Subtype/Image/Type/XObject/Width 536>>stream
HSS@
l"qꮊxTQlݝiuwG-rqٙ;ՙJ%7n** *,Mˆ$`rx@|~pԼ罝{ޱ1
BP(
BP(
BP(
BPo}zC_]Mϟ7 %:zdrX|